1Y Annualised Return
▼-2.37%
3Y Annualised Return
▲15.83%
5Y Annualised Return
▲17.27%
10Y Annualised Return
▲8.77%
Cipla Stock Performance
|
|
|
Cipla Company background
Cipla Overview
Cipla Limited was founded in 1935 by Khwaja Abdul Hamied and incorporated under its present name in 1984. Headquartered in Mumbai, Maharashtra, the company is listed on both NSE (CIPLA) and BSE (500087). It is a global pharmaceutical major focused on developing, manufacturing, and marketing generic and branded medicines across areas such as respiratory, cardiovascular, anti-retroviral, oncology, and consumer healthcare, both in India and internationally.
Cipla Business Segments and Revenue Model
Cipla operates through key verticals: Generic Pharmaceuticals, Branded Pharmaceuticals, Active Pharmaceuticals Ingredients (API), Specialty Therapies (including oncology and respiratory), and Consumer Healthcare. It generates revenue through the sale of pharmaceutical products to hospitals, clinics, and retailers, as well as through exports. Net interest income, though minimal, comes from its treasury investments. Its diverse global presence in markets like the US, Africa, and Europe ensures balanced revenue, with R&D-led specialty products enhancing margins alongside scale-driven generics.
Cipla Key Milestones
- 1935: Founded in Mumbai as Chemical, Industrial & Pharmaceutical Laboratories
- 1984: Renamed Cipla Limited
- 1995: Launched Deferiprone, the world’s first oral iron chelator
- 2006: Acquired remdesivir licence, launched Cipremi in India
- 2013: Acquired Cipla-Medpro (South Africa)
- 2015: Acquired U.S. generics firms InvaGen and Exelan for $555 million
- 2019: Ventured into digital therapeutics via partnerships in India and South Africa
- 2023: Acquired cosmetics distribution business of Ivia Beaute for ₹130 crore
- May 2025: Announced a combined ₹16/share dividend to mark its 90th anniversary
Cipla ESG and Sustainability
- CSR focus includes access to healthcare, education, women’s empowerment, and community health initiatives
- ESG mission emphasises strengthening healthcare access globally and reducing environmental impact through sustainable manufacturing and energy efficiency
- Long-term goal to align with global sustainability benchmarks and foster inclusive growth
Cipla Awards and Recognitions
- Thomson Reuters India Innovation Award (2012)
- Featured in Forbes “200 Best Under a Billion” list (2007)
- Chemexcil Award for excellence in exports (1980)
- Consistently recognised for innovation, quality, and corporate governance
Cipla Financial Highlights
Over the past
Cipla Fundamental
Market Cap (in crs)
1,26,752.77
Face Value
2
Turnover (in lacs)
18,232.10
Key Metrics
Cipla Key Financials
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
6957.47 Cr | 6729.69 Cr | 7072.97 Cr | 7051.02 Cr | 6693.94 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
28409.49 Cr | 26520.66 Cr | 23228.57 Cr | 22044.25 Cr | 19425.58 Cr | 17476.19 Cr |
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
1292.05 Cr | 1225.02 Cr | 1583.72 Cr | 1306.02 Cr | 1176.29 Cr |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
5291.05 Cr | 4155.31 Cr | 2835.49 Cr | 2559.47 Cr | 2401.3 Cr | 1546.98 Cr |
Cipla Result Highlights
Result Summary
-
Cipla Ltd reported a 12.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 5.3%.
-
Its expenses for the quarter were up by 5.7% QoQ and 3.9% YoY.
-
The net profit increased 38.6% QoQ and increased 9.9% YoY.
-
The earnings per share (EPS) of Cipla Ltd stood at 16.1 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Cipla Technical Analysis
Moving Averages Analysis
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 757134 Rs | 1177253 Rs |
Week Rs | 900650 Rs | 1353871 Rs |
Month Rs | 857084 Rs | 1426737 Rs |
Resistance & Support
Cipla Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
996.10 | 1,00,230.97 | 795 | 1139.95 | 991.05 | 0.84% | 4.96% | 13.63% | -10.39% | 170.17% | 1.10% | 22.48 | 40.13 | 4.73 | |
6,120.50 | 1,62,480.04 | 4955 | 7071.5 | 6,093.00 | -1.13% | -3.79% | 11.68% | 21.51% | 70.10% | 0.49% | 69.57 | 40.13 | 10.91 | |
1,253.70 | 1,04,632.04 | 1020 | 1414.99 | 1,279.90 | -0.75% | 2.71% | 12.29% | -8.78% | 49.61% | 0.64% | 15.22 | 40.13 | 3.64 | |
1,565.20 | 3,75,543.91 | 1553.05 | 1960.35 | 1,563.30 | -2.19% | -3.96% | -1.76% | -13.81% | 80.00% | 1.02% | 75.36 | 40.13 | 15.42 | |
3,582.90 | 1,21,256.17 | 2886.45 | 3787.9 | 3,584.30 | -0.61% | -2.59% | 21.53% | 4.47% | 135.74% | 0.17% | 61.01 | 40.13 | 15.97 | |
2,543.30 | 1,04,969.30 | 2115.1 | 3054.8 | 2,520.90 | 1.65% | -0.90% | 11.03% | 6.36% | 0.00% | 0.00% | 57.99 | 40.13 | 7.17 |
Cipla Latest News
Cipla Share Price FAQs
What is Share Price of Cipla ?
Cipla share price is ₹1569.2 in NSE and ₹1568.95 in BSE as on 2/9/2025.
How has Cipla shares performed in the past ?
Cipla share price in the past 1-year return was -4.7. The Cipla share hit a 1-year low of Rs. 1335 and a 1-year high of Rs. 1702.05.
What is the market cap of Cipla ?
The market cap of Cipla is Rs. 126752.77 Cr. as of 2/9/2025.
What is the current P/E ratio of Cipla ?
The PE ratios of Cipla is 24.53 as of 2/9/2025.
What is the current PB ratio of Cipla ?
The PB ratios of Cipla is 3.94 as of 2/9/2025
What is the Mutual Fund shareholding in Cipla ?
The Mutual Fund Shareholding in Cipla was 20.44% at the end of 2/9/2025.
How to buy Cipla shares?
You can easily buy Cipla shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Cipla ?
The 52-week high and low of Cipla share price is ₹1702.05 and ₹1335 as of 2/9/2025.
What is the EPS of Cipla ?
The earnings per share (EPS) of Cipla stood at 16.1 during Q1 FY 2025-26.
Please be aware that Cipla stock prices are subject to continuous fluctuations due to various factors.